Skip navigation

Vertex Pharmaceuticals Inc.

NMS : VRTX
Pharmaceuticals
Boston MA
2013 Revenue (US$ Millions)$1,212
2012 Revenue (US$ Millions)$1,527
Revenue Growth (%)-20.63%
Net Income (US$ Millions)($445)
Common Shares Outstanding (Millions)$234
Earnings Per Share (US$)($1.98)
Price To Earnings Ratio88.51
Total Equity (US$ Millions)$1,356
Profit Margin (%)-36.72%
Return On Equity (%)-44.54%
Long Term Debt (US$ Millions)$49
Debt To Equity Ratio (%)0.04%
Market Capitalization (US$ Millions)$17,371
Total Assets (US$ Millions)$2,319
Return on Assets (%)-16.13
Current Assets (US$ Millions)$1,589
Inventories (US$ Millions)$14
Current Liabilities (US$ Millions)$398
Cost of Goods Sold (US$ Millions)$89
Asset Turnover0.52
Inventory Turnover3.99
ExchangeNMS